Mucin biosynthesis and secretion in the respiratory tract. by Spicer, S S & Martinez, J R
Environmental Health Perspectives
Vol. 55, pp. 193-204, 1984
Mucin Biosynthesis and Secretion in the
Respiratory Tract
by S. S. Spicer* and J. R. Martinezt
The interface where most pulmonary toxicants ini-
tially encounter the respiratory tract lies at the luminal
surface of the tracheobronchial mucosa and pulmonary
alveoli. Providing the first barrier to injury from
environmental agents, this luminal surface requires
close scrutiny in a discussion of lung as a target organ.
Not surprisingly, the luminal surface ofthe respiratory
tract exhibits morphologic and biochemical features
uniquely adapted tothe maintenance ofsurface exposed
to air and not shared by intestinal, genitourinary or
other internalized epithelial surfaces. Most notably, a
heavy blanket of mucus covers the surface of the
tracheobronchial tree. This mucous blanket serves in
preventing dehydration, trapping inhaled particles and
microorganisms and in protecting against physical or
chemical injury to the various surface epithelial cells.
Propelled cephalad to the pharynx by the beat of
underlying cilia, the migrating mucous blanket facil-
itates removal offoreign materials in a process referred
to as mucociliary clearance. In addition, the respiratory
epithelium, like other epithelia, possesses a prominent
glycocalyx, rich in carbohydrate as its name implies, on
the luminal aspect ofthe apical plasmalemma ofall the
cells. The mucous blanket mediating mucociliary clear-
ance derives from secretion of cells in the surface
epithelium of the trachea, bronchi and bronchioles and
in submucosal glands of the trachea and bronchi. The
glycocalyx on the apical plasmalemma originates,
presumably, within the cell exhibiting the surface coat.
The following discussion focuses first on normal produc-
tion and secretion of the mucin on the surface of the
respiratory epithelium. The morphologic basis for mu-
cin production is described in terms of the various cell
types contributing to glycoconjugate-rich respiratory
secretions and the intracellular mechanisms for synthe-
sizing and releasing the macromolecules. Lacking mu-
cous secretory granules, the alveolar cells do not come
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into consideration. Biochemical and histochemical knowl-
edge ofthe nature ofthe secretion as a whole and as a
contribution from individual cell types is summarized
along with information pertaining to the physiologic
control of secretion. The effect of pulmonary toxicants
on the normal secretory mechanisms receives final
consideration.
Morphologic Aspects of Mucin
Production in the Respiratory Tract
Classification of Secretory Cells
Several differenttypes ofepithelial cells contribute to
the mucinous secretion in the respiratory tract (1-9). In
thetracheobronchial surfaceepithelium, mucousgoblet-
like cells, extending in man as far distally as do the
cartilage plates and to a variable extent beyond, pro-
duce carbohydrate-rich secretion. Cells secreting glyco-
conjugate in glands ofthe lamina propria include those
ofserous tubules and demilunes, ofmucous tubules and
of glandular ducts. The serous tubules and demilunes
empty into the mucous tubules which drain into
the intralobular and extralobular ducts, lined in part at
least by mucous goblet cells.
Viewed by electron microscopy, the cells in each of
these three categories appear to be classifiable into
subtypes on the basis ofthe number, size and shape of
their secretory granules and the distribution and den-
sity ofintragranular components with differingelectron
opacity. The presence or absence of a variably dense,
amorphous core in secretory granules, for example,
differentiates some from other cells in surface epithe-
lium and mucous tubules. Serous cells vary from one
another even more than mucous cells in the density and
distribution of one to three different zones within the
granule. Clara cells and secretory cells with sparse
small granules populating the surface epithelium ofthe
distal bronchioles display distinctive morphologic fea-
tures which have been well defined in rat (1,2,9) but
not in human bronchioles.SPICER AND MARTINEZ
Cell Mechanisms for Biosynthesis and
Secretion of Mucosubstances
The mechanisms underlying the synthesis of the
protein core of mucous glycoproteins have not been
studied in great detail, but are assumed to resemble the
conventional process responsible for the secretion of
secretory proteins. Protein synthesis in the ribosomes
involvesthreephases:initiation, elongationandtermina-
tion of the protein chain. The transport route of the
developing protein core in glycoprotein-secreting cells
does not differ, presumably, from that described for the
pancreas. However, the rate oftransport appears to be
slow (10). The peptide chain moves within the cisternal
space ofthe rough endoplasmic reticulum and migrates
toward that of the smooth endoplasmic reticulum.
Carbohydrates and sulfate are attached to the protein
during passage through the granular reticulum and the
Golgi area. Knowledge that the Golgi lamellae are a
main site of sugar and sulfate attachment is based on
evidence from ultrastructural, cytochemical and auto-
radiographic studies and on the finding that the activi-
ties ofthe glycosyltransferases are highest in subcellu-
lar fractions with characteristics of the Golgi elements
(11). Once supplied with their sugar and sulfate
components, the glycoproteins leave the Golgi cisternae
inside vesicles budding from the Golgi lamellae. These
vesicles fuse to form secretory granules which are
released by a merocrine or apocrine process of exocy-
tosis in response to secretory stimuli.
Mechanisms controlling the biosynthesis ofglycopro-
teins involve the regulation ofboth protein and oligosac-
charide synthesis (12). Genes control oligosaccharide
sequences in an indirect fashion, by functioning as
structural genes for the synthesis of glycosyltrans-
ferases and forthe biogenesis ofthe complexmembrane
systemwithin which the oligosaccharide assembly takes
place (11,12). The competence of the final glycocon-
jugate as a unique structure is determined by the
discrimination and specificity of the glycosyltransfer-
ases. Although mucous and serous cells have a similar
synthetic pathway, the mucous cells show a slower
uptake of H-threonine by the Golgi apparatus and a
slower turnover ofgranules than the serous cells (13). A
number of factors of genetic, developmental, chemical
and toxic nature can modify the biosynthesis of mucus
glycoproteins, by affecting either the synthesis of the
protein core ofthe glycoprotein molecule or the attach-
ment of the sugar components of these molecules (see
below).
Mucous glycoproteins are stored in secretory gran-
ules inside the epithelial cells, and there seems to be a
gradual and orderly shift of layered generations of
secretory granules toward the apex of the cell in
preparation for merocrine secretion which occurs by a
process called exocytosis. In this secretory process, the
membrane of the secretory granule fuses with the
plasma membrane and the granular content moves
through the fusion opening into the lumen. Since new
glycoproteins are synthesized continously and new se-
cretory granules are added to those formed earlier, the
cell has to remove granules from its store even in the
absence of a secretory stimulus. In exocrine cells the
redundant granules are secreted and, hence, fusions
between the granules and the plasma membrane are
observed even in unstimulated cells. Unstimulated
secretionhas alsobeenreported inmucous cells, butthe
process by which the glycoproteins leave the cell may
differ from what has been described for other types of
secretory proteins. There seems to be a disruption of
the apical rim of the plasma membrane and of the
underlying cytoplasm through which the membrane-
bound granule slips into the lumen where the mem-
brane disintegrates and the contents become free (14,
15).
The frequency of fusion between secretory granules
and the apical plasma membrane can be increased by
secretory stimuli including hormones, neurotransmit-
ters or drugs. The secretory cycles of mucous and
serous cells apparently differ. Mucous cells appear to
accumulate and discharge secretory macromolecules
constantly while serous cells have distinct phases of
accumulation and discharge (16,17).
Chemical Nature of Mucous
Secretions
Composition of Respiratory Secretions:
Cystic Fibrosis and Noncystic Fibrosis
Specimens Compared
The mucus secreted in the respiratory tract consti-
tutes a mobile and protective barrier which provides a
buffered, aqueous microenvironment to the airway
surface. This film ofmucus is primarily secreted by the
submucosal tracheobronchial glands and, to a lesser
extent, by the goblet cells ofthe surface epithelium (5).
The main constituents of respiratory secretion are
glycoproteins ofhigh molecular weight (6,18), but other
components including lysozyme, and immunoglobulins
are also present (19).
TIypically, mucus consists of about 1% of salts and
other dialysable components, 0.5 to 1% of free protein,
a similar proportion ofglycoprotein and 95% or more of
water. There is, in addition, a moderate amount oflipid
in bronchial mucus (20). The biological properties
of mucus are often altered in disease states and
through various experimental manipulations in labora-
tory animals.
Both histochemical and biochemical evidence sug-
gests that individual cell types in the airways are
capable of producing structurally distinctive glycopro-
teins (21,22). The analysis ofthe composition oftracheo-
bronchial secretions is complicated, however, by prac-
tical limitations in the accessibility to uncontaminated
secretions from specific cell types and from individual
portions oftherespiratory tree. Tracheobronchial secre-
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tions from healthy humans are difficult to obtain in
adequate amounts for detailed chemical analysis and
most studies on respiratory tract mucus have been
carried out on expectorated sputum. Specimens ob-
tained through lung lavage procedures and by fiberoptic
bronchoscopy or endoscopy have also been analyzed as
have secretions from nasal polyps and from tissue
explants in vitro. Similar approaches have been used in
animal species. Analyses were recently conducted in
our laboratory ofboth lung lavage and sputum samples
from cystic fibrosis (CF) and non-CF individuals, and
their chemical composition was compared (23,24). The
results of these studies on lavage samples are summa-
rized in lable 1. Non-CF material had 48.9% carbo-
hydrate, 33.8% protein and 12.3% lipid. The CF speci-
mens contained significantly increased levels of total
lipid, protein, phospholipid, neutral lipid, DNA and
RNA. They also contained significantly increased levels
of bound sulfate and were, therefore, more anionic in
nature.
Table 2 illustrates the water content, macromolecular
dry weight and the organic composition of sputa from
CF and non-CF sources. Samples were obtained by
postural drainage, by expectoration or by endotracheal
aspiration during bronchoscopy. CF samples were found
to be significantly less hydrated and to have higher
macromolecular dry weight, protein, lipid, phospha-
Table 1. Chemical composition of tracheobronchial secretions.
Composition, % of dry weightb
Componenta CF Non-CF
Total protein 42.7 33.8
Total lipid 19.8 12.3
Phospholipid 9.41 5.7
PS 1.20 1.04
PI 0.04 > 0.01
PE 2.17 1.47
PC 5.62 3.18
Neutral lipid 8.02 6.97
Glycolipid 1.58 1.78
Total carbohydrate 31.1 48.9
D-Ribose 9.81 1.01
Ribose 2.12 .08
Mannose 1.11 3.28
Glucose 1.69 2.54
Fucose 1.88 5.82
Galactose 3.54 10.37
N-CHO 5.17 14.87
S.A. 5.77 10.93
High molecular weight
glycoprotein 17.75 33.27
Protein 1 1
Fucose 0.49 1.21
Galactose 1.02 0.87
H-CHO 1.48 1.67
S.A. 1.71 1.54
S04 0.51 (8.63-11.21%) 0.41 (4.91-7.72%)
a Abbreviations: PS, phosphatidyl serine; PI, phosphatidyl inositol;
PE, phosphatidyl ethanoloamine; PC phosphatidyl choline; N-CHO,
amino-sugars; S.A., sialic acid; S04 , sulfate.
b Data are means of eight CF and six non-CF samples.
Table2. Chemical composition ofnonpurulent, purulentandcystic
fibrosis sputum.a
Composition, mglmL ± SDI
Constituent Nonpurulentb Purulent Cystic fibrosis
Water (mg/mL) 954± 15 934±12 886±31*
Macromolecular
dry weight 46±2.4 60±8.6+ 96±14.4
Protein 12.1±1.1 19.9±4.61 44.4±18.2t
Lipid 10.6±0.8 18.1±2.71 32.6±3.8'
Phosphatidyl-
choline
(% of total lipid) 27.1% 38.6% 51.0%'
Carbohydrate 9.2±1.4 12.3±1.41 14.3±2.4
Fucose
(% oftotal sugar) 18.2% 17.0% 14.1%
Sialic acid
(% oftotal sugar) 16.9% 21.4% 27.6%
DNA 0.008±0.002 0.820±0.281 2.730±1.12
No. samples
assayed 48 54 125
No. patients 31 47 21
a Unless otherwise designated.
b Nonpurulent sputum is defined as that having less than 0.025%
DNA content (based on macromolecular dry weight).
* Significance ofp < 0.005, Student t test, compared with nonpuru-
lent and purulent water content.
t Significance ofp < 0.001, Student t test, compared with nonpuru-
lent and purulent sputum values.
I Significance ofp < 0.005, Student t test, compared with nonpuru-
lent sputum values.
tidylcholine and DNA content when compared to both
purulent and nonpurulent sputum samples fromnon-CF
individuals. Although the total carbohydrate compo-
nent was also increased (Table 2), it actually comprised
less ofthe macromolecular dry weight. Further studies
indicated that the neutral and amino sugar molar ratios
were similar in CF and chronic bronchitis sputum
samples. However, the sialic acid and sulfate contents of
the CF samples were significantly higher.
Mucous Structure
Glycoproteins are polymeric substances consisting of
carbohydrate covalently linked to protein. The units
contain an average of8 to 10 monosaccharide residues of
five different types, including L-fucose, D-galactose,
N-acetyl-D-glucosamine, N-acetyl-D-galactosamine and
sialic acid (18). Carbohydrate units on glycoproteins
are, therefore, relatively small and are frequently
branched, have little or no repeating structure and do
not contain hexuronic acid. The linkage between carbo-
hydrate and protein in mucous glycoproteins is called
O-glycosidic because it is through an oxygen atom (6,
25) in contradistinction to the N-glycosydic linkage in
serum and membrane glycoprotein. The linkage sugar
in mucus glycoprotein isusuallyN-acetylgalactosamine,
which is joined to the hydroxyamino acids serine and
threonine of the protein chain (6,18,26) as compared
with the N-acetylglucosamine linkage to asparagine in
serumandmembraneglycoproteins. Mostmucousglyco-
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proteins contain over 50% carbohydrate. The physical
and chemical characteristics ofthe mucous glycoprotein
are determined, to a large extent, by its carbohydrate.
The protein component ofmucous glycoproteins is quite
characteristic and different from that of plasma glyco-
proteins in having a high content of serine, threonine
and proline, but only small amounts of aromatic and
sulfur-containing amino acids (18,22).
Qualitative and quantitative studies in several labora-
tories have analyzed sputum and secretion from tra-
cheal explants (6,17,27-29). The data suggest that
there is heterogeneity with regard to acidity and
molecular size ofthe carbohydrate side chains of acidic
bronchial mucins from CF and chronic bronchitis pa-
tients (22,30). Various types ofneutral and acidic (both
sulfated and sialylated) glycoproteins have been de-
scribed biochemically as well as histochemically in
respiratory tract mucins from a variety of animal
species (8,31-34).
Histochemical Observations
The mucous goblet cells of surface epithelium of
trachea and bronchi in man produce sulfated glycopro-
tein in some areas and mainly sialylated glycoproteins
or a mixture of both types in other areas as evidenced
by light microscopic methods for differentiating and
characterizing complex carbohydrates (8, unpublished
observations). Sialidase digestion imparts staining to
these cells by a method employing a peanut lectin-
horseradish peroxidase conjugate to localize terminal
galactose residues in glycoproteins (Fig. 1) (35). All
goblets of human respiratory surface epithelium stain
with the conjugate after but not before digestion with
sialidase, demonstrating that the oligosaccharide side
chains contain terminal sialic acid and penultimate
galactose (unpublished observations). The sulfate es-
ters evidenced histochemically in the goblet secretion
FIGURE 1. Human respiratory surface epithelium shows numerous intensely stained cells with apical globletlike accumulations of mucus.
Unstained ciliated cells are not evident. Secretion of mucous goblets lacks staining without sialidase digestion but, as shown here, gains
intense affinity for peanut lectin after digestion evidencing content of penultimate galactose residues under terminal sialic acid in the
oligosaccharide side chains ofthe glycoprotein. Carnoy fixation, 6 hr. Sialidase digestion, peanut lectin-horseradish peroxidase stain. x 500.
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apparently connect to internal residues ofthe glycopro-
tein side chains. Species variation is evident in that
goblet cells normally form almost exclusively a non-
sulfated sialomucin in the rat (9) and sulfomucin in the
dog (8).
Glands in the lamina propria display differences
among the histologic cell types in reactivity demonstra-
tive of glycoconjugate. Variability exists between spe-
cies in reactivity of a given type ofcell. In man, serous
tubules and demilunes store neutral glycoprotein in
granules of some cells and lightly sulfated glycoprotein
in granules of other cells.
The light to moderately intense staining of serous
cells for neutral or sulfated mucosubstance contrasts
with the strong reactivity of some mucous tubule cells
for sialomucin, others for sulfomucin and still others for
a mixture ofthe two components (4,8). These different
secretory products can be demonstrated by 35SO42
radioautography, by blue versus black staining with the
high iron diamine-Alcian blue sequence or by differ-
ences in staining with this method or the Alcian
blue-periodic acid Schiffsequence with orwithoutprior
sialidase (36). Lack of staining with the peanut lectin-
horseradish peroxidase conjugate before sialidase and
strong reactivity after digestion reveals that the secre-
tion throughout mucous cells in humantracheobronchial
glands contains terminal sialic acid and penultimate
galactose in the oligosaccharide side chains of the
secretory glycoprotein. Taken together, the basic dye
methods and the lectin procedures indicate that all the
mucous tubule cells produce sialylated glycoprotein and
this complex carbohydrate is sulfated to a moderate or
marked degree in some cells but not at all in others.
The histochemical results appear consistent with
production ofa single glycoprotein containing a variable
number ofsulfate esters in all the mucous goblet cells of
the surface epithelium of respiratory tract in man but
do not conclusively demonstrate this thesis. Except for
variable sulfation the mucosubstance could be similar
also throughout the cells of the mucous tubules aside
from extent of sulfation secretion in the surface goblet
cells generally resembles that in mucous cells of the
glands. However, the gland mucous cells differ some-
what from those of surface epithelium in staining a
more purple shade with the Alcian blue-periodic acid
sequence method, indicating a greater abundance of
vic-glycol-containing hexose in the glandular mucous
cells. The abundant serous cells of tracheobronchial
glands, on the other hand, appear to secrete one or
more different mucosubstances with a comparatively
low carbohydrate content and containing relatively
sparse sulfate esters in some and no sulfates in other
cells. Determining whether the serous and other types
ofsecretory cells each produce more than one macromo-
lecular species will require development of histochemi-
cal procedures with greater specificity. A challenging
problem for furtherinquiry concerns relating the differ-
ent secretions in the several histologic sites to the three
majormucous glycoproteins isolated by DEAE-cellulose
chromatography from human lung lavage fluid (28).
In addition to the histochemical localization of
mucosubstances an immunoperoxidase-bridge proce-
dure for immunocytochemical demonstration of anti-
gens in tissues has demonstrated lysozyme in lung. This
low molecular weight, cationic glycosidase has been
localized to secretory granules of tracheobronchial se-
rous cells and type 11 pneumocytes (37,38). The biologic
significance oflysozyme in these secretions presumably
pertains to its capacity to hydrolyze amino sugar
linkages in bacterial walls or, conceivably, in secretory
glycoproteins and its potential for forming electrostatic
complexes with anionic mucosubstances.
Employing cytochemical methods for visualizing
mucosubstances at the ultrastructural level has con-
firmed and extended the light microscopic findings in
rat trachea (Figs. 2-4) (9). The microscopic cytochemi-
cal approach has shown, in addition, the presence of
glycoconjugate in secretory granules ofcells such as the
Clara cells where it was not otherwise detectable (Fig.
5). The electron microscopic cytochemistry shows quan-
titative differences not evident by light microscopy in
carbohydrate content between individual cells ofagiven
histologic type (Figs. 2-4). Whether these also reflect
qualitative differences remains uncertain. The ultra-
structural methods demonstrative of vic-glycol-con-
taining hexose, or of carboxyl or sulfate groups, also
provide evidence for variability in intragranular distri-
bution of glycoconjugate among different cells of the
sametype. Theyshow, moreover, differencesinglycopro-
tein content among the secretory granule population of
a single cell profile, indicating granule heterogeneity
within a cell in human respiratory tract (unpublished
observation). Ultrastructural staining with cationic re-
agents has revealed, in addition, the distribution of
complex carbohydrates in zones within secretory gran-
ules and, on occasion, distinguished zones of heavy,
light and no reactivity within a granule profile. The
question here arises whether a different degree of
staining with the basic reagent in two zones of a single
secretory granule demonstrates qualitative or quantita-
tive differences incontent ofacid groupsintheglycopro-
teins in the two zones.
Ultrastructural staining of complex carbohydrates
also discloses a heavy mucosubstance-rich coat on the
luminal surface of the apical plasmalemma of most
surface epithelial cells in the respiratory tract (Figs. 3
and 4) (9). This glycocalyx varies quantitatively and
qualitatively on different cells. The complex carbohy-
drate in the glycocalyx coating the cilia, for example,
lacks demonstrable vic-glycol-containing hexoses al-
though showing staining for carboxyls, presumably in
neuraminic acid. The apical microvilli ofthe ciliated and
neighboring secretory cells, on the other hand, exhibit
cytochemically reactive glycoprotein with vic-glycol-
containing hexoses and carboxyl (Figs. 3 and 4). The
cilia glycocalyx, thus, appears different cytochemically
from luminal glycocalyx elsewhere in the respiratory
tract. A unique coat on the cilia could be envisioned as
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FIGURE 2. Surface epithelium of rat trachea composed of serous and ciliated cells. Granules in some serous cells exhibit a thin rim of
carbohydrate-rich material and those of other cells contain no complex carbohydrate. A cell at the far right encloses granules with a
moderately thick rim or cap containing well stained complex carbohydrate rich in periodate-reactive hexoses. Several types of serous cells
have been distinguished on the basis ofdistribution ofa carbohydrate-rich peripheral component (9). A mucous-type cell containing granules
with glycoprotein-rich, heavily stained matrix and an unreactive, eccentric nucleoid occupies the center ofthe field. Mucous cells, too, can be
subdivided onthebasis ofthe amountanddistribution ofglycoconjugates stainedbycytochemicalmethods (9). Periodicacidthiocarbohydrazed-
silver-proteinate (PA-TCH-SP) stain. x 5000.
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FIGURE 3. A serous cell at the left exhibiting stored secretory granules with a moderately thick rim of stained glycoprotein contrasts with
serous cells on either side ofthe central ciliated cells. The latter serous cells contain granules with only a thin glycoprotein-positive rim or a
cortex with a thin inner and outer band of reactivity. The apical plasmalemmae exhibit staining for glycoprotein, but the lateral
plasmalemmae and tight junctions lack reactivity. Tips ofthe microvilli show more intense staining. Microvilli (arrow) ofthe ciliated cells at
the center differ from the cilia in possessing a strongly stained glycocalyx. Lysosomes (L) in the ciliated cells reveal staining as do glycogen
particles scattered throughout the cytoplasm. PA-TCH-SP stain. x 10,000.
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FIGURE 4. Rat tracheal surface epithelium displays strongstainingdemonstrative ofabundant carboxyl or sulfate groupsthroughout the matrix
ofsecretory granules in the protruding cytoplasm ofthe mucous cell. Glycocalyx covering the surface ofthe cilia, microvilli on the ciliated cell
and the apical plasmalemma of the mucous cell all evidence strong affinity for the basic reagent. The strong basophilia in the glycocalyx
covering the ciliated cells contrasts with the lack ofperiodate reactivity indicative ofhexoses with vic-glycol groups. (cf. Fig. 3). Dialyzed iron
stain. x12,500.
having significance for the lubricating properties and
the protection against interciliary adhesion and friction
required for the synchronous beating of these closely
spaced, greatly elongated structures. This glycocalyx
conceivably constitutes a vulnerable site forunfavorable
action ofpulmonary toxicants ormicrobial enzymes, but
little is known concerning pathologic alteration of the
surface coat of cilia.
The histochemically evident differences between sur-
face epithelial mucous cells, glandular mucous cells and
serous cells emphasize again the longstanding questions
concerning biologic significance ofthese cell types. The
mucous blanket covering the cilia and mediating muco-
ciliary clearance undoubtedly derives from a mixture of
their secretions. Since glands are thought to produce a
many times greater volume of secretion than surface
epithelium (5), the goblet cells probably play a quantita-
tively minor role. Lying intermingled with neighboring
ciliated cells, the surface goblet cells influence more
directly, however, the secretion overlying the cilia. The
upstream location of serous cells distal to mucous cells
in the glands, the morphologic observation that serous
cells empty into constricted intercellular canaliculi and
the histochemical finding that the secretion of serous
cells is comparatively low in carbohydrate and acidity
support the view that the serous secretion is less
viscous and serves in diluting and flushing more viscous
secretion of downstream mucous cells through the
ducts. The recent immunocytochemical demonstration
of carbonic anhydrase selectively in serous cells of
humanbronchialglands (unpublished observations) sug-
gests active ion and fluid transport by these cells and
supports the view oftheircontributing a morehydrated,
less viscous secretion compared with mucous glands.
Myoepithelial cells underlying serous and mucous cells
apparently facilitate, by their potential for contractility,
the flow of macromolecule-rich, viscous secretion in
ducts. Stasis of secretion in ducts have been evidenced
in our observations on hypersecreting pathologic lung
by the dilatation of ducts containing abundant inspis-
sated secretion in the lumen and sparse stored secretion
in the cells.
Physiological Control of the
Secretion of Mucus in the Airways
Regulation by the Autonomic
Nervous System
The resting secretion of respiratory tract mucus has
never been accurately measured in healthy men. Pa-
tients with tracheostomies are said to secrete 10 to 15
mL/day. Resting secretion continues after vagotomy
and is also observed in organ culture preparations ofthe
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FIGURE 5. A Clara cell lining a terminal bronchiole in rat lung
encloses several apical granules which contain a central unstained
area with an angulated contour. Glycoprotein in the periphery of
these granules stains strongly In presumably more mature
granules of other cell profiles, the unstained central material
occasionally appears greatly elongated and glycoprotein encloses
the crystalloid center in a configuration reminiscent of eosinophil
crystalloid granules (9). The surface of the apical plasmalemma
displays less reactivity than that of the secretory cells higher in
the respiratory tract. (cf. Figs. 3 and 4). Its dialyzed iron affinity,
however, compares favorably with that of the proximal surface
epithelial cells. PA-TCH-SP stain. x 10,000.
trachea (39). Accordingly, it is thought that resting
secretion proceeds independently of innervation. The
autonomic nervous system, therefore, could be consid-
eredtoincreasetherestingsecretion. Electrical stimula-
tion of the vagus nerves promotes secretion of mucus
from the submucosal glands of the trachea (39,40).
Stimulation of sympathetic nerves also promotes secre-
tion of airway mucus in certain species, but not in
others (39,40). The secretion induced by sympathetic
stimulation is blocked by propranolol and mimicked by
isoproterenerol, so the response is probably mediated
by beta receptors (39,40). However, there is no evidence
of sympathetic innervation of the mucus secreting
tissues in human airways (39). It is not clear whether
the composition of water content of the secretions
elicited by parasympathetic and sympathetic stimula-
tions are the same. Cultures of explanted human
tracheobronchial tissues have been used to study mucus
secretion in vitro and have demonstrated that a basal
level of mucus secretion is present in both the mucous
and serous cells of the submucosal glands. This basal
level can be stimulated by parasympathomimetic drugs
such as acetylcholine or pilocarpine and inhibited by
cholinergic antagonists such as atropine (41-43). Sym-
pathomimetic drugs ortheir inhibitors have no effect on
mucus secretion in vitro (29,41,43).
Recent evidence has indicated, however, that in the
cat trachea alpha-adrenergic agonists enhance ion-
mediatedfluidsecretionandsecretionofmucus, presum-
ably from submucosal glands (44). The lack of effect of
alpha-adrenergic agents on mucus secretion in some
species may be attributable to absence or poor develop-
ment of submucosal glands.
The response ofmucous goblet cells or serous cells in
the surface epithelium is less clear. Goblet cell secretion
or changes in the cell's secretory capacity do not appear
to be under nervous control in the human lung (39,45).
Denervation ofthe lung has no effect on the number or
the types of goblet cells, and these cells show no
response to stimulation of the vagus nerve or to
parasympathomimetic drugs or antagonists such as
atropine (43,46). Nerve processes are not encountered
by electron microscopy in the vicinity of surface
epithelium as they are near submucosal glands (9). It
has been suggested, therefore, that goblet cells respond
only to local irritants or local reflexes (32,39,42).
However, the physiologicalcontrol ofsurface goblet cells
needs to be re-evaluated in view of the finding that
chronic administration of autonomic drugs such as
pilocarpine and isoproterenol produces both a hyperpla-
sia and a hypertrophy ofthe goblet cells in some species
(47,48). Furthermore, with experimental animals in
vivo, injections of sympathomimetic drugs into the
trachea or the bloodstream increase the secretion of
mucus in the airways. This is probably the result ofthe
stimulation of beta receptors, since the response is
prevented by propranolol (32,39).
Role of Peptides and Prostaglandins
Recent evidence indicates that other humoral factors
may be involved in the regulation ofmucus secretion in
the airways. Although histamine promotes secretion in
the cat trachea in high doses, this mediator is inactive
on mucus secretion ofhuman airways invitro (45). Both
the dog and the rat trachea respond to certain peptides,
such as substance P and kallidin, with an increased
secretion of mucous glycoproteins (49,50). The rat
trachea has also been recently shown in our laboratory
to respond to prostaglandins E1 and F20x with an
increased release of mucous glycoproteins. Table 3
shows the results of this experiment. Prostaglandins
A1, E1, E2, F1a, F2a have also been shown to increase
mucous glycoprotein secretion when applied directly to
the cat trachea (40). Prostaglandin F20 was also found
to be the most effective stimulant of human sputum
production (40).
Specific Cellular Responses to Stimulation
From studies on the secretion of mucus by cat
trachea, it has been concluded that pilocarpine provokes
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Table 3. Release of 3H-labeled glycoproteins.
Release of glycoproteins, DPMa
Stimulant Control Reserpine
None (baseline) 464±87 944±127
Bradykinin 621±62 1531± 144
Substance P 895± 101 2018±193
Prostaglandin E1 1109± 121 3778±350
Prostaglandin F2 1582 ±298 7681 ±325
Prostaglandin E1 + F2 2788±236 12343± 548
a DataexpressedasDPM ± SDreleasedbytracheas 10minfollowing
stimulant addition.
the release of sulfated glycoproteins while irritants
produce glycoproteins with a low sulfate content and a
high sialic acid content (39,40). The question arises
concerning the cellular source of these different secre-
tions. Conceivably the surface epithelial goblet cells,
lacking an autonomic response mechanism account for
the low sulfate, high sialic acid secretion induced by
irritants. In absence of histochemical knowledge of
glycoconjugate in the feline trachea, it can only be
speculated that the cat resembles the rat where surface
goblet cells produce nonsulfated, sialylated glycosub-
stance whereas mucous tubules of glands secrete
sulfomucin (9). Low sulfate secretion could not derive
from surface mucous cells in man and dog because
surface goblets form sulfomucin in these species (8).
The secretions originating from the epithelial goblet
cells have been compared biochemically with those of
the submucosal glands in explants from the dog trachea
that were denuded of the surface epithelium. It was
concluded that goblet cell secretions arehighly sulfated,
an observation that was confirmed by autoradiography
in double-label experiments with glucosamine and sul-
fate (51) and by histochemistry (8). Biochemical charac-
terization of the lateral secretions indicated that the
submucosal glands contain a mixture of acidic mucins
and histochemical methods yield comparable informa-
tion (8). The species differences indicate the difficulties
in extrapolating findings from one species to another
and caution against interpreting the cell source of a
secretion induced in one species on the basis of knowl-
edge of the type of secretion produced by the various
cell types in another species.
Basic Mechanism of Secretion
The basic mechanism by which chemical mediators
and drugs act to modify the secretion of mucus in the
airways has been little investigated. In other exocrine
glands such as the pancreas and the salivary glands,
cyclic nucleotides and calcium have been implicated as
intracellular mediators of the stimulus secretion cou-
pling mechanism (52,53). There is some evidence,
however, that the same mediators may be involved in
the secretion of glycoproteins by the respiratory
epithelium. Thus, addition of cyclic AMP promotes
secretion by human airways in organ culture and
theophylline also promotes secretion by inhibiting
phosphodiesterases (39). Recent experiments in an
isolated perfused preparation of the rat trachea con-
ducted in our laboratory have also indicated that cyclic
nucleotides of guanine and adenine promote glycopro-
tein secretion in this tissue and that their effects are
additive (54). Calcium ions also seem to be involved in
the secretory process. In the same experiments indi-
cated above, substitution of calcium for other divalent
cations in the incubation medium in which the isolated
rat trachea was perfused resulted in a complete inhibi-
tion of the secretory response to cholinergic agents.
The possible relationship between glycoprotein secre-
tion and the transepithelial transport of electrolytes
and water in the airways has received little attention.
Thetwo processes maybeintimately linked, however, as
suggested by recent experiments in our laboratory
which demonstrated that the enhanced secretion of
glycoprotein induced in the perfused rat trachea by
acetylcholine was abolished when Na+ or Cl- was
substituted by other monovalent ions in the fluid
bathing the preparation (55). The coupling between the
two processes during the response to physiological
regulators can have important implications, when
disturbed, in the pathogenesis of the pulmonary mani-
festations of certain pulmonary diseases characterized
by hypersecretion of physicochemical alterations of
mucus. Increasing experimental evidence indicates,
furthermore, that electrolyte transport is an important
component ofthe secretory response in the airways and
that it involves electrolyte fluxes of different extents
and directions in the various segments of the airway
epithelium (45).
Effects of Toxicants on Secretion of
Mucus
Drugs
Experiments in our laboratory have indicated that
the chronic administration ofreserpine to rats produces
a widespread exocrine gland disturbance similar in
several ways to that observed in cystic fibrosis (56-58).
In rat submandibular glands, for example, chronic
reserpine treatment causes increased storage of secre-
tory granules, and depletion of the granular reticulum
and Golgi lamellae and acts to diminish the response to
secretogogues (59). Reserpine also causes an enhanced
secretion of mucous glycoproteins in the respiratory
tract and an increased sensitivity of the secretory
elements to stimulation with autonomic mediators (47,
60). The trachea ofthe reserpine-treated animals is not
only more susceptible to autonomic mediators but also
to other potential humoral mediators, including pep-
tides and prostaglandins (50). The mechanism by which
chronic reserpine administration may induce these
changes in the secretory elements of the respiratory
tract is not entirely clear at present. In other exocrine
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tissues, this drug regimen produces a very marked
direct toxic effect in addition to its effect on the
catecholamine stores of the tissues, (57,58).
The chronic administration ofisoproterenol orpilocar-
pine to rats has been shown to cause goblet cell
hyperplasia and submucosal gland hypertrophy (48).
Lung lavage samples from normal rats treated with
these two agents for 12 days were analyzed in our
laboratory and the results indicated that chronic
isoproterenol administration caused a 2.5-fold increase
in the lipid content, but no change in the protein or
carbohydrate content of such samples. Chronic treat-
ment with pilocarpine resulted, on the other hand, in
2.6-, 3.3- and 1.9-fold increases in the protein, lipid and
carbohydrate contents of these samples (47). Rats
previously treated with reserpine and then exposed to
isoproterenol or pilocarpine for 12 days showed a
greater sensitivity to the two drugs and increased
contents of protein, carbohydrate and lipid in the lung
lavage samples (47). Isoproterenol is thought primarily
to affect glycoprotein synthesis, rather than discharge,
whereas chronic pilocarpine causes an indirect effect on
discharge (48). The specific effects of autonomic drugs
and their antagonists onthe various aspects ofglycopro-
tein synthesis and secretion in the respiratory tract
needs more careful examination. A particularly impor-
tant question concerns the specific cell types that are
affected by acute or chronic exposure to the different
drugs.
Chemicals and Irritants
Many studies have shown that acute inhalation of
chemical irritants increases the secretion of mucus or
the glycoprotein output in the airways (3,6,7,21,33,
61-63). Repeated exposure of animals to chemical
irritants such as sulfur dioxide, ammonia vapor and
tobacco smoke causes structural and functional changes
in the secretory elements of the airways.
Dogs exposed to chronic inhalation of sulfur dioxide,
for example, display extreme hyperplasia of both mu-
cous goblet cells in surface epithelium and submucosal
glands (Fig. 6) (64,65). Mucous goblet cells increase in
size and number in surface epithelium, suggesting
transformation of ciliated cells into mucous cells or
proliferation of undifferentiated cells selectively into
mucous cells. Conversion ofserous cells to mucous cells
has also been proposed (21,33,62). Wide separation of
ciliated cells by hyperplasia of mucous cells in these
dogs could burden the mucociliary clearance, not only
through increasing the mucous load from goblet cell
secretion, but also by introducing gaps of nonciliated
cells unable to participate in moving the mucus. Such a
mechanismpossibly explains the conspicuous adherence
of luminal mucus to the epithelial surface and the
polypoid organization ofluminal mucous observed in the
dog trachea after SO2 irritation (65).
The effects ofpulmonary toxicants are usually associ-
ated both with changes in the chemical composition of
the secreted mucus involving the production of more
acidic glycoproteins and with altered physical proper-
ties of this mucus (21,33,62). Hypertrophy of the
surface goblet cells and submucosal glands during
chronic exposure of dogs to sulfur dioxide is accompa-
nied by increased activity of some of the glycosyl
transferases in the respiratory tract (64). This increase
could be attributed to the mucous cell hyperplasia
evident histochemically.
The mechanisms responsible for the response of
mucous-secreting cells to irritants have not been gener-
ally well analyzed but, presumably, involve both reflex
and direct stimulation of the mucous-secreting cells. A
further possibility is that chemical irritants cause
release of glycoproteins from the surface layer of
FIGURE 6. Abronchus from an SO2 treated dog (65) shows hyperplastic mucous goblet cells in the overlying surface epithelium and hyperplastic
dilated glands containing secretion stained for glycoprotein in the lamina propria below. Alcian blue-periodic acid Schiff stain. x 500.
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ciliated epithelial cells, possibly the glycocalyx. In
general, secretory cells that have undergone hypertro-
phy or hyperplasia tend to show an enhanced secretion
of mucus and a hypersensitivity to stimulants. In the
case of the mucous-secreting cells of the submucosal
glands, the heightened secretion seems to be propor-
tional to the degree ofgland hypertrophy in the airway
(33,46). There is evidence, moreover, that exposure to
irritants also alters the balance of synthesis and dis-
charge of mucus in the secretory cells (33). Thus, in
S02-treated dogs, basophilia demonstrative of sulfate
esters and periodic acid-Schiff staining demonstrative
of hexoses in the hyperplastic surface goblet cells
appeared decreased, indicating that an increased secre-
tory rate resulted in decreased storage of secretion in
apical granules of the irritant response cells (65). The
same pattern ofresponse is observed in certain chronic
lung diseases such as cystic fibrosis, chronic bronchitis
and bronchiectasis. In each case, there is gland
hypertrophy, mucus hypersecretion andhyper-reactivity
ofthe secretory elements to stimulation of parasympa-
thomimetic agents (13,46).
Infection
Submucosal gland hypertrophy and changes in the
acidity of glycoproteins are also observed in pigs with
enzootic pneumonia induced by Mycoplasma (21,33).
The proportion of acid glycoprotein (both sulfated and
neuraminidase-sensitive sialylated glycoproteins) in-
creases, and modifications ofthe intracellular granules,
are evident ultrastructurally. Dogs hypersensitive to
ascaris and chronically exposed to ascaris antigen
evidenced luminal casts composed of sulfated glycocon-
jugate in ducts oftracheal and bronchial glands suggest-
ing a residual stasis following prior hypersecretion (66).
An increased pulmonary infiltrate ofmast cells in these
dogs was possibly related to asensitivity state. Inocula-
tion ofrats withPseudomonas aeruginosa embedded in
agar beads has been shown to cause hyperplasia and
metaplasia of goblet cells (67), but it is not known
whether this results in alterations of mucous glyco-
proteins.
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